Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Gammon, G' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 12 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. O'Day, SJ; Boasberg, PD; Kristedja, TS; Martin, M; Wang, HJ; Fournier, P; Cabot, M; DeGregorio, MW; Gammon, G
      High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma

      CANCER
    2. O'Day, SJ; Gammon, G; Boasberg, PD; Martin, MA; Kristedja, TS; Guo, M; Stern, S; Edwards, S; Fournier, P; Weisberg, M; Cannon, M; Fawzy, NW; Johnson, TD; Essner, R; Foshag, LJ; Morton, DL
      Advantages of concurrent biochemotherapy modified by decrescendo interleukin-2, granulocyte colony-stimulating factor, and tamoxifen for patients with metastatic melanoma

      JOURNAL OF CLINICAL ONCOLOGY
    3. Rawlins, P; Mander, T; Sadeghi, R; Hill, S; Gammon, G; Foxwell, B; Wrigley, S; Moore, M
      Inhibition of endotoxin-induced TNF-alpha production in macrophages by 5Z-7-oxo-zeaenol and other fungal resorcylic acid lactones

      INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY
    4. OLLILA DW; KELLEY MC; GAMMON G; MORTON DL
      OVERVIEW OF MELANOMA VACCINES - ACTIVE SPECIFIC IMMUNOTHERAPY FOR MELANOMA PATIENTS

      Seminars in surgical oncology
    5. HOON DSB; OKAMOTO T; WANG HJ; ELASHOFF R; NIZZE AJ; FOSHAG LJ; GAMMON G; MORTON DL
      IS THE SURVIVAL OF MELANOMA PATIENTS RECEIVING POLYVALENT MELANOMA CELL VACCINE LINKED TO THE HUMAN-LEUKOCYTE ANTIGEN PHENOTYPE OF PATIENTS

      Journal of clinical oncology
    6. MANDER T; HILL S; HUGHES A; RAWLINS P; CLARK C; GAMMON G; FOXWELL B; MOORE M
      DIFFERENTIAL-EFFECTS ON TNF-ALPHA PRODUCTION BY PHARMACOLOGICAL AGENTS WITH VARYING MOLECULAR SITES OF ACTION

      International journal of immunopharmacology
    7. CONFORTI AM; OLLILA DW; KELLEY MC; GAMMON G; MORTON DL
      UPDATE ON ACTIVE SPECIFIC IMMUNOTHERAPY WITH MELANOMA VACCINES

      Journal of surgical oncology
    8. BROWN D; SADEGHI R; STEEL J; MOORE M; GAMMON G
      DETECTION OF INTERLEUKIN-1 SIGNAL-TRANSDUCTION INHIBITORS - ACTION OFPROTEIN-KINASE INHIBITORS

      International journal of immunopharmacology
    9. GAMMON G; CHANDLER G; DEPLEDGE P; ELCOCK C; WRIGLEY S; MOORE J; CAMMAROTA G; SINIGAGLIA F; MOORE M
      A FUNGAL METABOLITE WHICH INHIBITS THE INTERACTION OF CD4 WITH MAJOR HISTOCOMPATIBILITY COMPLEX-ENCODED CLASS-II MOLECULES

      European Journal of Immunology
    10. GAMMON G; EDGER D; MCBRIDE WH; SERCARZ EE
      COMPLICATIONS IN THE FUNCTIONAL-ANALYSIS OF TRANSFECTED MHC GENES

      Cellular immunology
    11. CHANDLER G; ELCOCK C; DEPLEDGE P; WRIGLEY S; MOUS J; MALKOVSKY M; MOORE M; GAMMON G
      CD4-BINDING COMPOUNDS - AN ASSAY TO DETECT NEW CLASSES OF IMMUNOPHARMACOLOGICAL AGENTS

      International journal of immunopharmacology
    12. LEHMANN PV; SERCARZ EE; FORSTHUBER T; DAYAN CM; GAMMON G
      DETERMINANT SPREADING AND THE DYNAMICS OF THE AUTOIMMUNE T-CELL REPERTOIRE

      Immunology today


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 07:39:03